WHO recommends follow-up care, low-dose anticoagulants for COVID-19 patients


By Liu Qu

GENEVA, Jan. 26 (Xinhua) -- Patients with suspected or confirmed COVID-19 should have access to follow-up care if they have persistent, new or changing symptoms, while hospitalized patients should use low-dose anticoagulants to prevent clots from forming in blood vessels, the World Health Organization (WHO) recommended on Tuesday.

In a statement, the WHO cited evidence gathered on the post-COVID condition, also known as "long COVID," in which people who have recovered from COVID-19 continue to experience longer-term symptoms like extreme fatigue, persistent cough and exercise intolerance.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

   

Next In Tech News

TikTok artists and advertisers to stay with app until 'door slams shut'
TikTok to suspend TikTok Lite's reward programme amid EU concerns
ASML approves Christophe Fouquet as CEO at annual meeting
AT&T beats estimates for subscriber additions, free cash flow
Exclusive-Google rival Tuta complains to EU tech regulators about de-ranking
Microsoft's AI lead puts Amazon cloud dominance on watch
TE Connectivity beats quarterly profit estimates on sensor demand
UK watchdog seeks views on Microsoft's and Amazon's AI partnerships
Texas Instruments' upbeat Q2 forecast pushes chip stocks higher
Italy fines Amazon over ‘recurring’ purchase option

Others Also Read